Search results
Ray Therapeutics, a clinical stage biopharmaceutical company, is currently investigating their lead optogenetic therapy candidate, RTx-015, in early stage clinical trials for those with RP and Choroideremia.
A round-up of the latest research into inherited retinal conditions - February 2024.
If you have a child with a visual impairment joining your class, you may have questions about how best you can teach and help them.
Retina UK has joined with more than 80 disability charities who have today written to the Chancellor calling for urgent support with the cost of living for disabled people.
Join #TeamRetinaUK at the Chester Marathon 2026 and proudly run in support of our vital work.
Celebrate the life of your loved one, by donating in their memory and help us fund more research and support, now.
Find out how you can mark your special day while fundraising for people with inherited sight loss.
Our monthly e-Newsletter featuring the latest updates from Retina UK. Subscribe now to receive these updates directly to your email.
Catherine L’Estrange, aged 11 from London has become the first individual in the UK to receive an investigative gene therapy treatment for retinal dystrophy associated with the BBS10 gene.
Be a part of our 50th anniversary team at the iconic Milan Marathon 2026! Join #TeamRetinaUK and soak up the incredible atmosphere as you run through the historic Italian city.
